Résultats de la recherche
10
Tout
Rechercher les filtres
Mot-clé
medical research
Oncocyte to Release Fourth Quarter 2024 Results on March 24, 2025
18 mars 2025 16h05 HE
|
OncoCyte Corporation
Oncocyte to Release Fourth Quarter 2024 Results on March 24, 2025
Progress Update on Halberd, Athena GTX and Athena Telemedicine Partnership, LLC Joint Projects
17 mars 2025 08h00 HE
|
Halberd Corp.
Progress Update on Halberd, Athena GTX and Athena Telemedicine Partnership, LLC Joint Projects
Aclarion Provides Shareholder Update
13 mars 2025 09h25 HE
|
Aclarion, Inc.
Aclarion Files Shareholder Update
Aclarion Announces Expansion Plans with RadNet Affiliates in New York and New Jersey
06 mars 2025 09h35 HE
|
Aclarion, Inc.
Aclarion Announces Expansion Plans with RadNet Affiliates
in New York and New Jersey
Aclarion, Inc. Announces Adjournment of Special Meeting of Stockholders
28 févr. 2025 16h01 HE
|
Aclarion, Inc.
Aclarion, Inc. Announces Adjournment of Special Meeting of Stockholders
Aclarion to Showcase Groundbreaking NOCISCAN Technology at the 2025 Spine Summit
20 févr. 2025 06h00 HE
|
Aclarion, Inc.
Aclarion to Showcase Groundbreaking NOCISCAN Technology
at the 2025 Spine Summit
Aclarion Receives US Patent to Protect Expanded Applications of Magnetic Resonance Spectroscopy (MRS) Data Processing to Identify Pain and Infection Biomarkers Throughout the Body
11 févr. 2025 07h58 HE
|
Aclarion, Inc.
Aclarion Receives US Patent to Protect Expanded Applications of Magnetic Resonance Spectroscopy (MRS) Data Processing
Oncocyte Prices $29.1 Million Equity Offering
10 févr. 2025 08h30 HE
|
OncoCyte Corporation
Oncocyte Prices $29.1 Million Equity Offering
Catheter Precision Inc. Engages PCG Advisory to Broaden Investor Relations Strategy
10 févr. 2025 08h00 HE
|
Catheter Precision Inc.
Catheter Precision Inc. Engages PCG Advisory to Broaden Investor Relations Strategy
Aclarion Announces Northwestern Medicine as First CLARITY Trial Site
06 févr. 2025 07h23 HE
|
Aclarion, Inc.
Aclarion Announces Northwestern Medicine as First CLARITY Trial Site